Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05806840 · ClinicalTrials.gov registry record · NA

Rapid Adaptation to Prevent Drug Use

A NA study of Substance Use, sponsored by Wayne State University.

Active
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT05806840 is a NA study of Substance Use that is active but no longer recruiting, run by Wayne State University. The registered enrollment target is 12 participants, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05806840, a NA study of Substance Use, is active but no longer recruiting, sponsored by Wayne State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

Using a 2-group, mixed method cluster randomized trial design, this study will compare standard implementation versus RAPD implementation strategy in Michigan Middle Schools

Conditions Studied

Interventions

  • BEHAVIORAL Rapid Adaptation to Prevent Drug Use (RAPD)
  • BEHAVIORAL Standard Implementation

Study Locations (1)

Michigan

  • Wayne State University - Detroit

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2023-09-06
Est. Completion 2025-07-31
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT05806840

The ClinicalTrials.gov registry entry for NCT05806840 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,260-participant average among 88 other Substance Use trials with a reported enrollment target (99% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which Rapid Adaptation to Prevent Drug Use (RAPD) is the first listed.

NCT05806840 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05806840 about?

NCT05806840 is a clinical study titled "Rapid Adaptation to Prevent Drug Use". Using a 2-group, mixed method cluster randomized trial design, this study will compare standard implementation versus RAPD implementation strategy in Michigan Middle Schools

What is the current status of trial NCT05806840?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2023-09-06. Estimated completion is 2025-07-31.

What conditions does trial NCT05806840 study?

This clinical trial studies the following conditions: Substance Use.

What interventions are being tested in trial NCT05806840?

The interventions under investigation include: Rapid Adaptation to Prevent Drug Use (RAPD) (BEHAVIORAL), Standard Implementation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05806840?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05806840 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.